CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 19, 2023--<a ...
BRENTWOOD, Tenn. & PORT WENTWORTH, Ga.--(BUSINESS WIRE)--Oct 19, 2023--<a ...
CHICAGO--(BUSINESS WIRE)--Oct 19, 2023--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, today announced that preliminary safety and efficacy data from its ongoing Phase 2 clinical trial, THIO-101, was accepted ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Oct 19, 2023--<a ...
PRINCETON, N.J.--(BUSINESS WIRE)--Oct 19, 2023--<a ...
LILLE, France--(BUSINESS WIRE)--Oct 19, 2023--4Moving Biotech, a spin-off of 4P-Pharma dedicated to facing the global challenge of knee osteoarthritis, announces that it has reached a significant milestone by completing patient recruitment for its LASARE Phase I clinical trial.This press ...
